-
November 20, 2021 CYBIN CEO Doug Drysdale On How CYB-003 Is Better Than Psilocybin | Next Gen PsychedelicsIn this episode of the Spotlight On, James Hallifax from the Psychedelic Investor, interviews Doug...
-
November 18, 2021 Daniel Carcillo On Psychedelics For TBI, Wesana Partnering With MAPS & Mike Tyson CollaborationDuring our time at Wonderland Miami, $PSYC CEO, David Flores, had the pleasure of sitting...
-
November 18, 2021 We NEED to Talk about the Compass Pathways Psilocybin-for-Depression Trial Results: A WIN for CMPS??In today's episode, we discuss the results of the much awaited phase 2b clinical trial...
-
November 17, 2021 Interview with Sa’ad Shah, Managing Partner at Noetic FundIn our conversation, Sa’ad gives us an overview of how his interest in philosophy led...
-
November 17, 2021 Atai Life Sciences, Compass Pathways, MindMed & Cybin’s Q3 Financial Results Analysis – What’s Next?Analyzing the Quarter 3 financial results of atai Life Sciences (Nasdaq: ATAI), Compass Pathways (Nasdaq:...
-
November 4, 2021 Compass Pathways launching NEW Phase II Clinical Trial to Treat PTSD!!!Compass Pathways is launching a NEW Phase II clinical trial to treat PTSD!!! The trial...
-
November 3, 2021 Interview with Awais Spall, Functional Diagnostic Nutrition Practitioner at Integrative OasisIn this conversation, we discuss some critical points such as how he managed to heal...
-
October 30, 2021 NEW MindMed MDMA trials, Compass Pathways Patent, Small Pharma DMT Trials Begins | MNMD, CMPS, DMTNEW MindMed MDMA trials, Compass Pathways Patent, Small Pharma DMT Trials Begins | MNMD, CMPS,...
-
October 22, 2021 Interview with Zoe Helene, Founder of Cosmic SisterIn our conversation, we discuss some of Zoe’s formative experiences in the creative arts which...
-
October 21, 2021 A NEW Psilocybin-Depression Study Was Just Released: The Results Are BREATHTAKING | GAME OVER?🚀🍄A NEW Psilocybin-Depression Study Was Just Released: The Results Are BREATHTAKING | GAME OVER?🚀🍄 Hello...
